A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
← catalyst calendarNCT05683977 · readout in 194 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →. With Kappa Santé.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
254actual
Sites
34
Country
France
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-11-14 | actual | When the study began enrolling |
| Primary completion | 2027-03-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-03-01 | estimated | The whole study's end, after follow-up |
| First posted | 2023-01-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Small Cell Lung Carcinoma
Intervention
- Drug: durvalumab
Primary outcome
what the primary-completion date above is the date OFThe time to first line treatment discontinuation (TTD).
measured TTD is defined as the time from the index date to the date of last durvalumab infusion (+3 weeks during induction period and +4 weeks during maintenance period) or date of death (up to 36 months)).
Publications
- PMID 32354495 — reports results
- PMID 35141799 — cited as background
- PMID 25310425 — cited as background
- PMID 26536193 — cited as background
- PMID 2997406 — cited as background
- PMID 26762738 — cited as background
- PMID 30280641 — cited as background
- PMID 26723244 — cited as background
- PMID 35279527 — cited as background
- PMID 31590988 — cited as background
- PMID 27107787 — cited as background
- PMID 31378235 — cited as background
- PMID 28465554 — cited as background
- PMID 7165009 — cited as background
- PMID 28888101 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed